...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
【24h】

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

机译:血浆交换对5%白蛋白的疗效和安全性,以改变阿尔茨海默病患者的脑脊液和血浆淀粉样蛋白β浓度和认知结果:多中心,随机,受控临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Studies conducted in animal models and humans suggest the presence of a dynamic equilibrium of amyloid-beta (A beta) peptide between cerebrospinal fluid (CSF) and plasma compartments.
机译:背景:在动物模型和人体中进行的研究表明脑脊液(CSF)和等离子体隔室之间的淀粉样蛋白β(β)肽的动态平衡存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号